Immunovant logo

Immunovant

Immunovant, Inc. is a clinical-stage biopharmaceutical company focused on enabling normal lives for patients with autoimmune diseases. Immunovant is developing IMVT-1401, a novel, fully human anti-FcRn monoclonal antibody, as a subcutaneous injection for the treatment of autoimmune diseases mediated... Read more

Industries

Employees

51-200

Links


Org chart

Collapse

Board & advisors


Teams


Offices